Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | VP and Chief Legal Officer | August 10, 2026 | August 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date August 10, 2026 · Filed August 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 3,344 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-10 · Exercise / conversion · Acquired 6,786 · Balance 9,222 Row 2 · 2026-08-10 · Tax withholding · Disposed 5,878 · Balance 3,344 F1: Payment of purchase price and tax obligation on stock option exercise. |
| Stock Option (right to buy with tandem tax withholding)SEC Table II · derivative / convertible security · Conversion / exercise price $445.35 · Expires 2026-10-28 | Direct | 31,281 |
Reported balance
After 2026-08-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-10 · Exercise / conversion · Disposed 6,786 · Balance 31,281 F2: Vesting in three equal annual installments commencing 10/28/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Payment of purchase price and tax obligation on stock option exercise.
F2: Vesting in three equal annual installments commencing 10/28/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 10, 2026 18:29 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 6,786 | $445.35 Strike: $445.35 | $3,022,145.10 |
DisclosureSEC source: 0001193125-26-342087 · ownership.xml · derivative · entry 3 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,281 Underlying: Capital Stock · 6,786 shares Expires 2026-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 18:29 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 5,878 | $548.96 | $3,226,786.88 |
DisclosureSEC source: 0001193125-26-342087 · ownership.xml · nonDerivative · entry 2 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,344 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 18:29 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 6,786 | $445.35 | $3,022,145.10 |
DisclosureSEC source: 0001193125-26-342087 · ownership.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Stock Units · Derivative | 908 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · derivative · entry 6 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,306 Underlying: Capital Stock · 908 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 283 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · derivative · entry 5 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,398 Underlying: Capital Stock · 283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 283 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · derivative · entry 4 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,681 Underlying: Capital Stock · 283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 102 | $469.56 | $47,895.12 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · nonDerivative · entry 3 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,436 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 0 | $469.56 | $0.00 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · nonDerivative · entry 2 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 351 | $469.56 | $164,815.56 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 20:26 UTC | CHEMED CORP CHE · Entity 3723 | GrantStock Option (right to buy with tandem tax withholding) · Derivative | 15,017 | $443.79 Strike: $443.79 | $6,664,394.43 |
DisclosureSEC source: 0001193125-25-246834 · ownership.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,067 Underlying: Capital Stock · 15,017 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:14 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022124 · ownership.xml · derivative · entry 6 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,964 Underlying: Capital Stock · 750 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock. F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022124 · ownership.xml · derivative · entry 5 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,214 Underlying: Capital Stock · 275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. F5 · derivative.expiration_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Stock Units · Derivative | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022124 · ownership.xml · derivative · entry 4 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,489 Underlying: Capital Stock · 275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. F5 · derivative.expiration_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 215 | $553.39 | $118,978.85 |
DisclosureSEC source: 0000950170-25-022124 · ownership.xml · nonDerivative · entry 3 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,187 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 168 | $553.39 | $92,969.52 |
DisclosureSEC source: 0000950170-25-022124 · ownership.xml · nonDerivative · entry 2 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2022 through December 31, 2024, compared to a defined peer group of companies. The Company's performance ranked in the 31.3 percentile of that group, yielding an award of 60.4%; including the reinvestment of dividends paid during such period, the award is 61.0% of target. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 20:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 556 | $553.39 | $307,684.84 |
DisclosureSEC source: 0000950170-25-022124 · ownership.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performace stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2022 through December 31, 2024. The actual performance of $64.97 exceeded the maximum payout threshold of $63.75 and therefore yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target. Read SEC document |
| December 30, 2024 Filed Dec 30, 2024 16:10 UTC | CHEMED CORP CHE · Entity 3723 | PurchaseCapital Stock | 145 | $519.50 | $75,327.50 |
DisclosureSEC source: 0000950170-24-140988 · ownership.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,678 Read SEC document |
| October 22, 2024 Filed Oct 23, 2024 19:31 UTC | CHEMED CORP CHE · Entity 3723 | GrantStock Option (right to buy with tandem tax withholding) · Derivative | 10,323 | $597.70 Strike: $597.70 | $6,170,057.10 |
DisclosureSEC source: 0000950170-24-116602 · ownership.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,373 Underlying: Capital Stock · 10,323 shares Expires 2029-10-22 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/22/2025 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 15:26 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 6,133 | $471.74 Strike: $471.74 | $2,893,181.42 |
DisclosureSEC source: 0000950170-24-035162 · ownership.xml · derivative · entry 5 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,050 Underlying: Capital Stock · 6,133 shares Expires 2025-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 15:26 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock option (right to buy with tandem tax withholding) · Derivative | 5,825 | $413.19 Strike: $413.19 | $2,406,831.75 |
DisclosureSEC source: 0000950170-24-035162 · ownership.xml · derivative · entry 4 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,183 Underlying: Capital Stock · 5,825 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 15:26 UTC | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 11,158 | $645.00 | $7,196,910.00 |
DisclosureSEC source: 0000950170-24-035162 · ownership.xml · nonDerivative · entry 3 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,422 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiples transactions at prices ranging from $642.00 to $649.00. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 15:26 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 6,133 | $471.74 | $2,893,181.42 |
DisclosureSEC source: 0000950170-24-035162 · ownership.xml · nonDerivative · entry 2 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 15:26 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 5,825 | $413.19 | $2,406,831.75 |
DisclosureSEC source: 0000950170-24-035162 · ownership.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Dec 20, 2024 15:38 UTC Amendment | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 6,133 | $471.74 Strike: $471.74 | $2,893,181.42 |
DisclosureSEC source: 0000950170-24-138847 · ownership.xml · derivative · entry 5 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,050 Underlying: Capital Stock · 6,133 shares Expires 2025-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
| March 20, 2024 Filed Dec 20, 2024 15:38 UTC Amendment | CHEMED CORP CHE · Entity 3723 | Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 5,825 | $413.19 Strike: $413.19 | $2,406,831.75 |
DisclosureSEC source: 0000950170-24-138847 · ownership.xml · derivative · entry 4 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,183 Underlying: Capital Stock · 5,825 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| March 20, 2024 Filed Dec 20, 2024 15:38 UTC Amendment | CHEMED CORP CHE · Entity 3723 | SaleCapital Stock | 11,158 | $645.00 | $7,196,910.00 |
DisclosureSEC source: 0000950170-24-138847 · ownership.xml · nonDerivative · entry 3 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,533 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $642.00 to $649.00. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4. Read SEC document |
| March 20, 2024 Filed Dec 20, 2024 15:38 UTC Amendment | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 6,133 | $471.74 | $2,893,181.42 |
DisclosureSEC source: 0000950170-24-138847 · ownership.xml · nonDerivative · entry 2 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Dec 20, 2024 15:38 UTC Amendment | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 5,825 | $413.19 | $2,406,831.75 |
DisclosureSEC source: 0000950170-24-138847 · ownership.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amended filing due to administrative error Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:22 UTC | CHEMED CORP CHE · Entity 3723 | GrantPerformance Share Units · Derivative | 648 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017019 · ownership.xml · derivative · entry 6 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,764 Underlying: Capital Stock · 648 shares Expires not disclosed F6 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Chemed Capital Stock. F7 · derivative.exercise_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2024 to December 31, 2026. The determination of the performance level is to be made by March 15, 2027 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2024 to December 31, 2026. The determination of the performance level is to be made by March 15, 2027 and earned shares to be delivered thereafter. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:22 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Share Units · Derivative | 236 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017019 · ownership.xml · derivative · entry 5 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,116 Underlying: Capital Stock · 236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. F5 · derivative.expiration_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:22 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionPerformance Share Units · Derivative | 236 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017019 · ownership.xml · derivative · entry 4 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,352 Underlying: Capital Stock · 236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. F5 · derivative.expiration_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:22 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingCapital Stock | 110 | $586.49 | $64,513.90 |
DisclosureSEC source: 0000950170-24-017019 · ownership.xml · nonDerivative · entry 3 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 733 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:22 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 221 | $586.49 | $129,614.29 |
DisclosureSEC source: 0000950170-24-017019 · ownership.xml · nonDerivative · entry 2 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2021 through December 31, 2023 compared to a defined peer group of companies. The Company's performance ranked in the 47th percentile of that group, yielding an award of 92.6%; including the reinvestment of dividends paid during such period, the award is 93.4% of target. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 20:22 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionCapital Stock | 147 | $586.49 | $86,214.03 |
DisclosureSEC source: 0000950170-24-017019 · ownership.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSUs") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2021 through December 31, 2023. The actual performance of 5.47% yielded an award of 61.7% of target; including the reinvestment of dividends paid during such period, the award is 62.2% of target. Read SEC document |
| October 25, 2023 Filed Oct 26, 2023 17:23 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 9,664 | $509.46 Strike: $509.46 | $4,923,421.44 |
DisclosureSEC source: 0001209191-23-053633 · doc4.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,008 Underlying: capital stock · 9,664 shares Expires 2028-10-25 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/25/2024. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:46 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 566 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011564 · doc4.xml · derivative · entry 6 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,588 Underlying: capital stock · 566 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026 and earned shares to be delivered thereafter. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:46 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011564 · doc4.xml · derivative · entry 5 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022 Underlying: capital stock · 185 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. F5 · derivative.expiration_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:46 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011564 · doc4.xml · derivative · entry 4 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,207 Underlying: capital stock · 185 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. F5 · derivative.expiration_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:46 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 175 | $515.12 | $90,146.00 |
DisclosureSEC source: 0001209191-23-011564 · doc4.xml · nonDerivative · entry 3 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:46 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 213 | $515.12 | $109,720.56 |
DisclosureSEC source: 0001209191-23-011564 · doc4.xml · nonDerivative · entry 2 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2020 through December 31, 2022, compared to a defined peer group of companies. The Company's performance ranked in the 55.6th percentile of that group, yielding an award of 113.89%; including the reinvestment of dividends paid during such period, the award is 115% of target. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 19:46 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 374 | $515.12 | $192,654.88 |
DisclosureSEC source: 0001209191-23-011564 · doc4.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSUs") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2020 through December 31, 2022. The actual performance of 12.67% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202% of target. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 14:11 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 6,600 | $462.04 Strike: $462.04 | $3,049,464.00 |
DisclosureSEC source: 0001209191-22-055179 · doc4.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,344 Underlying: capital stock · 6,600 shares Expires 2027-10-31 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/31/2023 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 17:58 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012080 · doc4.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,392 Underlying: capital stock · 550 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F2 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025 and earned shares to be delivered thereafter. F2 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025 and earned shares to be delivered thereafter. Read SEC document |
| December 31, 2021 Filed Feb 8, 2022 15:59 UTC | CHEMED CORP CHE · Entity 3723 | Purchasecapital stock | 1 | $531.29 | $531.29 |
DisclosureSEC source: 0001209191-22-007666 · doc5.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · kind: Additional share purchased in Savings & Retirement Plan Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 18:02 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 6,786 | $445.35 Strike: $445.35 | $3,022,145.10 |
DisclosureSEC source: 0001209191-21-062322 · doc4.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,744 Underlying: capital stock · 6,786 shares Expires 2026-10-28 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 19:34 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 472 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013102 · doc4.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 842 Underlying: capital stock · 472 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F2 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2021 to December 31, 2023. The determination of the performance level is to be made by March 15, 2024 and earned shares to be delivered thereafter. F2 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2021 to December 31, 2023. The determination of the performance level is to be made by March 15, 2024 and earned shares to be delivered thereafter. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 17:48 UTC Amendment | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 6,133 | $471.74 Strike: $471.47 | $2,893,181.42 |
DisclosureSEC source: 0001209191-20-056308 · doc4a.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,958 Underlying: capital stock · 6,133 shares Expires 2025-10-29 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 16:22 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 6,133 | $471.74 Strike: $471.74 | $2,893,181.42 |
DisclosureSEC source: 0001209191-20-056295 · doc4.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,958 Underlying: capital stock · 6,133 shares Expires 2025-10-29 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.